drugset / Trial / NCT04886297

A Dose-response Study of Dietary Resveratrol on Lipid Metabolism Disorder

NCT04886297

Phase 3 Completed 168 enrolled Sun Yat-sen University
RandomizedParallel-groupDouble-blindPrevention

Summary

In order to study the effect of resveratrol on the improvement of lipid and uric acid metabolism, randomized intervention trials were conducted to compare the effects of resveratrol on the improvement of lipid and uric acid metabolism in different dose groups. To explore the best dose of resveratrol for the prevention and treatment of metabolic diseases provide an important scientific basis.

Timeline

Start
2021-05-01
Primary completion
2022-05-30
Completion
2022-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Resveratrol Small molecule 100 mg Oral
Subject Resveratrol Small molecule 300 mg Oral
Subject Resveratrol Small molecule 600 mg Oral

Indications